Search Results1-7 of  7

  • Hideyuki MIZUMA ID: 9000400185000

    Articles in CiNii:1

    • <Abstract of Published Report>Microsphere Embolism-induced Elevation of Nerve Growth Factor Level and Appearance of Nerve Growth Factor Immunoreactivity in Activated T-Lymphocytes in the rat Brain. (2000)
  • MIZUMA Hideyuki ID: 9000002281404

    Articles in CiNii:1

    • <Abstract of Published Report>Microsphere Embolism-induced Elevation of Nerve Growth Factor Level and Appearance of Nerve Growth Factor Immunoreactivity in Activated T-Lymphocytes in the rat Brain. (2000)
  • MIZUMA Hideyuki ID: 9000003126923

    Statistics Working Group, Japan Pharmaceutical Manufactures Association (1998 from CiNii)

    Articles in CiNii:1

    • Investigation on statistical methods for quantitative data of repeated dose toxicity studies in rats (1998)
  • MIZUMA Hideyuki ID: 9000391992611

    Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures Association (2009 from CiNii)

    Articles in CiNii:1

    • Questionnaire Survey for Establishment of Photosafety Evaluation Procedures (2009)
  • MIZUMA Hideyuki ID: 9000391993563

    Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures Association- (2009 from CiNii)

    Articles in CiNii:1

    • Current Status of Short-term Carcinogenicity Study Using Genetically-engineered Mice -Questionnaire Survey and Literature Research of Japan Pharmaceutical Manufacturers Association- (2009)
  • MIZUMA Hideyuki ID: 9000391999646

    Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (2009 from CiNii)

    Articles in CiNii:1

    • Safety Evaluation for Chiral Pharmaceuticals (1) – Questionnaire Survey of Japan Pharmaceutical Manufacturers Association – (2009)
  • MIZUMA Hideyuki ID: 9000391999685

    Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (2009 from CiNii)

    Articles in CiNii:1

    • Safety Evaluation for Chiral Pharmaceuticals (2) – Investigation of NDA Documents and Assessment Reports in Japan – (2009)
Page Top